Sec62 bridges the gap from 3q amplification to molecular cell biology in nonsmall cell lung cancer

American Journal of Pathology

Volumn 180, Issue 2, 2012, Pages 473-483

  Linxweiler, Maximilian ^a   Linxweiler, Johannes ^a   Barth, Monika ^a   Benedix, Julia ^a   Jung, Volker ^a   Kim, Yoo Jin ^a   Bohle, Rainer M ^a   Zimmermann, Richard ^a   Greiner, Markus ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; THAPSIGARGIN;

ARTICLE; CANCER TISSUE; CELL DEDIFFERENTIATION; CELL MIGRATION; CHROMOSOME 3Q; CONTROLLED STUDY; ENDOPLASMIC RETICULUM STRESS; GENE; GENE AMPLIFICATION; GENE LOCUS; GENE SILENCING; HUMAN; HUMAN TISSUE; IN VITRO STUDY; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; PRIORITY JOURNAL; SEC62 GENE; THYROID CANCER; TUMOR CELL;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; BLOTTING, WESTERN; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CELL MOVEMENT; CHROMOSOMES, HUMAN, PAIR 3; DNA TOPOISOMERASES, TYPE II; DNA-BINDING PROTEINS; ENDOPLASMIC RETICULUM STRESS; ENZYME INHIBITORS; GENE AMPLIFICATION; GENE SILENCING; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MEMBRANE TRANSPORT PROTEINS; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; THAPSIGARGIN; THYROID NEOPLASMS;

EID: 84862908615     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2011.10.039     Document Type: Article

References (50)

1. J. Ferlay, H.R. Shin, F. Bray, D. Forman, C. Mathers, D.M. Parkin Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 Int J Cancer 127 2010 2893 2917
2. G. Lo Russo, F. Franchi, P. Seminara Is CEA better than CYFRA 21-1 in the monitoring of squamous cell lung cancer progression? Med Princ Pract 20 2011 200
3. B. Nisman, H. Biran, N. Ramu, N. Heching, V. Barak, T. Peretz The diagnostic and prognostic value of ProGRP in lung cancer Anticancer Res 29 2009 4827 4832
4. G.E. Carpagnano, M.P. Foschino-Barbaro, O. Resta, E. Gramiccioni, F. Carpagnano Endothelin-1 is increased in the breath condensate of patients with non-small-cell lung cancer Oncology 66 2004 180 184
5. J.G. Paez, P.A. Jnne, J.C. Lee, S. Tracy, H. Greulich, S. Gabriel, P. Herman, F.J. Kaye, N. Lindeman, T.J. Boggon, K. Naoki, H. Sasaki, Y. Fujii, M.J. Eck, W.R. Sellers, B.E. Johnson, M. Meyerson EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy Science 304 2004 1497 1500
6. A. Potti, S. Mukherjee, R. Petersen, H.K. Dressman, A. Bild, J. Koontz, R. Kratzke, M.A. Watson, M. Kelley, G.S. Ginsburg, M. West, D.H. Harpole JR., J.R. Nevins A genomic strategy to refine prognosis in eraly-stage non-small-cell lung cancer N Engl J Med 355 2006 570 580
7. M. Maemondo, A. Inoue, K. Kobayashi, S. Sugawara, S. Oizumi, H. Isobe, A. Gemma, M. Harada, H. Yoshizawa, I. Kinoshita, Y. Fujita, S. Okinaga, H. Hirano, K. Yoshimori, T. Harada, T. Ogura, M. Ando, H. Miyazawa, T. Tanaka, Y. Saljo, K. Hagiwara, S. Morita, T. Nukiwa Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR N Engl J Med 362 2010 2380 2388
8. F.I. Bray, E. Weiderpass Lung cancer mortality in 36 European countries: secular trends and birth cohort patterns by sex and region 19702007 Int J Cancer 126 2009 1454 1466
9. R.S. Herbst, J.V. Heymach, S.M. Lippman Lung cancer N Engl J Med 359 2008 1367 1380
10. T. Sato, Y. Murakumo, S. Hagiwara, S. Jijiwa, C. Suzuki, Y. Yatabe, M. Takahashi High-level expression of CD109 is frequently detected in lung squamous cell carcinoma Pathol Int 57 2007 719 724
11. C. Moran Importance of molecular features of non-small cell lung cancer for choice of treatment Am J Pathol 178 2011 1940 1948
12. E. Dehan, A. Ben-Dor, W. Liao, D. Lipson, H. Frimer, S. Rienstein, D. Simansky, M. Krupsky, P. Yaron, E. Friedman, G. Rechavi, M. Periman, A. Aviram-Goldring, S. Izraeli, M. Bittner, Z. Yakhini, N. Kaminski Chromosomal aberrations and gene expression profiles in non-small cell lung cancer Lung Cancer 56 2007 175 184
13. P.P. Massion, P.M. Taflan, S.M. Jamshedur Rahman, P. Yildiz, Y. Shyr, M.E. Edgerton, M.D. Westfall, J.R. Roberts, J.A. Pietenpol, D.P. Carbone, A.L. Gonzalez Significance of p63 amplification and overexpression in lung cancer development and prognosis Cancer Res 63 2003 7113 7121
14. A.M. Bjrkvist, K. Husgafvel-Pursiainen, S. Anttila, A. Karjalainen, L. Tammilehto, K. Mattson, H. Vainio, S. Knuutila DNA gains in 3q occur frequently in squamous cell carcinoma of the lung, but not in adenocarcinoma Genes Chrom Cancer 22 1998 79 82
15. M. Chujo, T. Noguchi, T. Miura, M. Arinaga, Y. Uchida, Y. Tagawa Comparative genomic hybridization analysis detected frequent overrepresentation of chromosome 3q in squamous cell carcinoma of the lung Lung Cancer 38 2002 23 29
16. N.P. Caraway, A. Khanna, M. Dawlett, M. Guo, N. Guo, E. Lin, R.L. Katz Gain of the 3q26 region in cervicovaginal liquid-based pap preparations is associated with squamous intraepithelial lesions and squamous cell carcinoma Gynecol Oncol 110 2008 37 42
17. Y. Mori, F. Sato, F.M. Selaru, A. Olaru, K. Perry, M.C. Kimos, G. Tamura, N. Matsubara, S. Wang, Y. Xu, J. Yin, T.T. Zou, B. Leggett, J. Young, T. Nukiwa, O.C. Stine, J.M. Abraham, D. Shibata, S.J. Meltzer Instabilotyping reveals unique mutational spectra in microsatellite-unstable gastric cancers Cancer Res 62 2002 3641 3645
18. Y.C. Chang, K.T. Yeh, T.C. Liu, J.G. Chang Molecular cytogenetic characterization of esophageal cancer detected by comparative genomic hybridization J Clin Lab Anal 24 2010 167 174
19. J.J.C. Sheu, C.H. Lee, J.Y. Ko, G.S.W. Tsao, C.C. Wu, C.Y. Fang, F.J. Tsai, C.H. Hua, C.L. Chen, J.Y. Chen Chromosome 3p12.3-p14.2 and 3q26.2-q26.32 are genomic markers for prognosis of advanced nasopharyngeal carcinoma Cancer Epidemiol Biomarkers Prev 18 2009 2709 2716
20. F. McCaughan, J.C.M. Pole, A.T. Bankier, B.A. Konfortov, B. Carroll, M. Falzon, T.H. Rabbitts, P.J. George, P.H. Dear, P.H. Rabbitts Progressive 3q amplification consistently targets SOX2 in preinvasive squamous lung cancer Am J Respir Crit Care Med 182 2010 83 91
21. N. Comtesse, A. Keller, I. Diesinger, C. Bauer, K. Kayser, H. Huwer, H.P. Lenhof, E. Meese Frequent overexpression of the genes FXR1 CLAMP1 and EIF4G located on amplicon 3q26-27 in squamous cell carcinoma of the lung Int J Cancer 120 2007 2538 2544
22. P.P. Massion, W.L. Kuo, D. Stokoe, A.B. Olshen, P.A. Treseler, K. Chin, C. Chen, D. Polikoff, A.N. Jain, D. Finkel, D.G. Albertson, D.M. Jablons, J.W. Gray Genomic copy number analysis of non-small cell lung cancer using array comparative genomic hybridization: implications of the phosphatidylinositol 3-kinase pathway Cancer Res 62 2002 3636 3640
23. J. Qian, P.P. Massion Role of chromosome 3q amplification in lung cancer J Thorac Oncol 3 2008 212 215
24. V. Jung, R. Kindich, J. Kamradt, M. Jung, M. Mller, W.A. Schulz, R. Engers, G. Unteregger, M. Stckle, R. Zimmermann, B. Wullich Genomic and expression analysis of the 3q25-q26 amplification unit reveals TLOC1/SEC62 as a probable target gene in prostate cancer Mol Cancer Res 4 2006 169 176
25. M. Greiner, B. Kreutzer, S. Lang, V. Jung, A. Cavali, G. Unteregger, R. Zimmermann, B. Wullich Sec62 protein level is crucial for the ER-Stress tolerance of prostate cancer Prostate 71 2011 1074 1083
26. M. Greiner, B. Kreutzer, V. Jung, R. Grobholz, A. Hasenfus, R.F. Sthr, L. Tornillo, J. Dudek, M. Stckle, G. Unteregger, J. Kamradt, B. Wullich, R. Zimmermann Silencing of the Sec62 gene inhibits migratory and invasive potential of various tumor cells Int J Cancer 128 2011 2284 2295
27. A. Ribeiro-Silva, H. Zhang, S.S. Jeffrey RNA extraction from ten year old formalin-fixed paraffin-embedded breast cancer samples: a comparison of column purification and magnetic bead-based technologies BMC Mol Biol 8 2007 118
28. P.P. Reis, L. Waldron, R.S. Goswami, W. Xu, Y. Xuan, B. Perez-Ordonez, P. Gullane, J. Irish, I. Jurisica, S. Kamel-Reid mRNA transcript quantification in archival samples using multiplexed, color-coded probes BMC Biotechnol 11 2011 46
29. H. Zhao, N.R. Bertos, M. Park RNA isolation from FFPE tissues: comparing the performances of three commercial kits Biochemica 4 2008 33 34
30. T method Nat Protoc 6 2008 1101 1108
31. D.W. Liu, S.T. Chen, H.P. Liu Choice of endogenous control for gene expression in nonsmall cell lung cancer Eur Respir J 26 2005 1002 1008
32. S. Saviozzi, F. Cordero, M. Lo Iacono, S. Novello, G.V. Scagliotti, R.A. Calogero Selection of suitable reference genes for accurate normalization of gene expression profile studies in non-small cell lung cancer BMC Cancer 6 2006 200
33. F. Zhang, Z.M. Wang, H.Y. Liu, Y. Bai, S. Wei, Y. Li, M. Wang, J. Chen, Q.H. Zhou Application of RT-PCR in formalin-fixed and paraffin-embedded lung cancer tissues Acta Pharmacol Sin 31 2010 111 117
34. D.G. Ginzinger Gene quantification using real-time quantitative PCR: an emerging technology hits the mainstream Exp Hematol 30 2002 503 512
35. W. Remmele, H.E. Stegner Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue Pathologe 8 1987 138 140
36. R. Kindich, A.R. Florl, V. Jung, R. Engers, M. Mller, W.A. Schulz, B. Wullich Application of a modified real-time PCR technique for relative gene copy number quantification to the determination of a relationship between NKX3.1 loss and MYC gain in prostate cancer Clin Chem 51 2005 649 652
37. A.S. Lee, L.M. Hendershot ER stress and cancer Cancer Biol Ther 5 2006 721 722
38. C. Koumenis ER stress, hypoxia tolerance and tumor progression Curr Mol Med 6 2006 55 69
39. M. Bi, C. Naczki, M. Koritzimsky, D. Fels, J. Blais, N. Hu, H. Harding, I. Novoa, M. Varia, J. Raleigh, D. Scheuner, R.J. Kaufman, J. Bell, D. Ron, B.G. Wouters, C. Koumenis ER stress-regulated translation increases tolerance to extreme hypoxia and promotes tumor growth EMBO J 24 2005 3470 3481
40. Y. Liu, B.K. Law, H. Luesch Apratoxin A reversibly inhibits the secretory pathway by preventing cotranslational translocation Mol Pharmacol 76 2009 91 104
41. K. Heselmeyer, E. Schrck, S. Du Manoir, H. Blegen, K. Shah, R. Steinbeck, G. Auer, T. Ried Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix Proc Natl Acad Sci U S A 93 1996 479 484
42. G.R. Jalali, T.J. Herzog, B. Dziura, R. Walat, M.W. Kilpatrick Amplification of the chromosome 3q26 region shows high negative predictive value for non-malignant transformation of LSIL cytologic finding Am J Obstet Gynecol 202 2010 581.e1 581.e5
43. R.J. Christie, N. Nishiyama, K. Kataoka Delivering the code: polyplex carriers for deoxyribonucleic acid and ribonucleic acid interference therapies Endocrinology 151 2009 466 473
44. L. Bonetta RNA-based therapeutics: ready for delivery? Cell 136 2009 581 584
45. L. Crin, E. Dansin, P. Garrido, F. Griesinger, J. Laskin, N. Pavlakis, D. Stroikovski, N. Thatcher, C.M. Tsai, Y.L. Wu, C. Zhou Safety and efficacy of first-line bevacizumab-based therapy in advanced non-squamous non-small cell lung cancer (SAiL. MO19390): a phase 4 study Lancet Oncol 11 2010 733 740
46. E.L. Kwak, Y.J. Bang, D.R. Camidge, A.T. Shaw, B. Solomon, R.G. Maki, S.H. Ou, B.J. Dezube, P.A. Janne, D.B. Costa, M. Varella-Garcia, W.H. Kim, T.J. Lynch, P. Fidias, H. Stubbs, J.A. Engelman, L.V. Sequist, W. Tan, L. Gandhi, M. Mino-Kenudson, G.C. Wei, S.M. Shreeve, M.J. Ratain, J. Settleman, J.G. Christensen, D.A. Haber, K. Wilner, R. Salgia, G.I. Shapiro, J.W. Clark, A.J. Iafrate Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer N Engl J Med 363 2010 1693 1703
47. A. Ghantous, H. Gali-Muhtasib, H. Vuorela, N.A. Salina, N. Darwiche What made sesquiterpene lactones reach cancer clinical trials? Drug Discov Today 15 2010 668 678
48. A.M. Winther, H. Liu, Y. Sonntag, C. Oelsen, M. le Maire, H. Soehoel, C.E. Olsen, S.B. Christensen, P. Nissen, J.V. Moller Critical roles of hydrophobicity and orientation of side chains for inactivation of sarcoplasmic reticulum Ca2+-ATPase with thapsigargin and thapsigargin analogs J Biol Chem 285 2010 28883 28892
49. J.M. Backer, A.V. Krivoshein, C.V. Hamby, J. Pizzonia, K.S. Gilbert, Y.S. Ray, A.W. Paton, J.C. Paton, M.V. Backer Chaperone-targeting cytotoxin and endoplasmic reticulum stress-inducing drug synergize to kill cancer cells Neoplasia 11 2009 1165 1173
50. M.V. Backer, J.M. Backer, P. Chinnaiyan Targeting the unfolded protein response in cancer therapy Methods Enzymol 491 2011 37 56